Skip to search formSkip to main contentSkip to account menu

E 7010

Known as: E-7010, E7010 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Tubulin is the proposed target for drugs against cancer and helminths and is also a validated target in kinetoplastid parasites… 
Highly Cited
2002
Highly Cited
2002
A series of small molecules from sulfonamide-focused libraries have been evaluated in these laboratories to discover novel… 
Highly Cited
2002
2000
2000
Abstract. Purpose: E7010 is an orally active sulfonamide antitumor agent showing good activity against various subcutaneously… 
Highly Cited
1999
Highly Cited
1999
Tubulin binding agents (TBAs) reduce tumor perfusion and inhibit mitosis of tumor cells in solid tumors, but it is not clear… 
Highly Cited
1998
Highly Cited
1998
Abstract E7010 is a novel sulfonamide which was discovered using slow-growing colon 38 carcinoma cells as a screening model… 
1998
1998
N‐[2‐[(4‐Hydroxyphenyl)amino]‐3‐pyridyl]‐4‐methoxybenzenesulfonamide (E7010) is a novel sulfonamide antimitotic agent, which is… 
Highly Cited
1997
Highly Cited
1997
Dolastatin 10, a pentapeptide isolated from the marine mollusk Dolabella auricularia, has antitumor activity. TZT‐1027, a…